Drugs / Oligofructose
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 21 trial · 1 missed | ||||||
| Phase 2 | NCT02124759 | Apr 2014 → Feb 2018 | — | The University of Texas Health Science Center at San Antonio | Completed | Missed primary |
| Comparator or background therapy1 trial | ||||||
| Phase 2 | NCT02127125 Comparator | Apr 2014 → Sep 2018 | — | The University of Texas Health Science Center at San Antonio | Completed | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | oligofructose | “5 g of oligofructose + 1 g Bifidobacterium longum R0175 (4 billion colony forming units (CFU)/g) three times a day.” NCT02124759 ↗1“5 g of oligofructose + 1 g Bifidobacterium longum R0175” NCT02127125 ↗ |